0001127602-12-006494.txt : 20120216
0001127602-12-006494.hdr.sgml : 20120216
20120216212619
ACCESSION NUMBER: 0001127602-12-006494
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120213
FILED AS OF DATE: 20120216
DATE AS OF CHANGE: 20120216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harper Sean E
CENTRAL INDEX KEY: 0001541946
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 12620872
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
3
1
form3.xml
PRIMARY DOCUMENT
X0204
3
2012-02-13
0
0000318154
AMGEN INC
AMGN
0001541946
Harper Sean E
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
EVP, Research & Development
Common Stock
42150
D
Iso (Right to Buy)
71.88
2010-04-03
2013-04-03
Common Stock
1391
D
Nqso (Right to Buy)
71.88
2007-04-03
2013-04-03
Common Stock
16109
D
Nqso (Right to Buy)
69.78
2008-02-08
2014-02-08
Common Stock
14400
D
Nqso (Right to Buy)
42.13
2012-04-29
2015-04-29
Common Stock
6000
D
Nqso (Right to Buy)
50.44
2012-04-28
2016-04-28
Common Stock
16000
D
Nqso (Right to Buy)
58.43
2012-04-26
2020-04-26
Common Stock
24000
D
Nqso (Right to Buy)
54.69
2013-04-25
2021-04-25
Common Stock
21000
D
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,450 RSUs which fully vest on 4/29/2012; 2,250 RSUs which vest in two equal annual installments of 1,125 each commencing 4/28/2012; 3,450 RSUs which vest in three equal annual installments of 1,150 each commencing 4/26/2012; 25,000 RSUs which fully vest on 12/31/2014; and 6,000 RSUs which vest in two equal installments of 1,980 each on 4/25/2013 and 4/25/2014 and one installment of 2,040 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These stock options were fully exercisable on April 3, 2010.
These stock options were fully exercisable on February 8, 2011.
These stock options are exercisable in two annual installments of 8,000 each commencing 4/28/2012.
These stock options are exercisable in three annual installments of 8,000 each commencing 4/26/2012.
These stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively.
/s/ Sean E. Harper
2012-02-15
EX-24
2
doc1.txt
POA
Exhibit 24
Power of Attorney
Know all men by these presents, that the undersigned hereby
constitutes and appoints each of John C. Ayres, Richard T. Benson and
Andrea A. Robinson, signing singly, the undersigneds true and lawful
attorney-in-fact to execute for and on behalf of the undersigned Forms 3,
4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended, and the rules thereunder, as may be required as a result
of the undersigneds position as an officer and/or director of Amgen Inc.
(the Company).
The undersigned hereby grants to each such attorney-in-fact
full power and authority to execute such Forms 3, 4 and 5 as fully to all
intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such attorney-in-facts
substitute or substitutes, shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigneds
responsibilities to comply with Section 16 of the Securities Exchange Act
of 1934, as amended.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4
and 5 with respect to the undersigneds holdings of and transactions
in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-
in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 30th day of January, 2012.
/s/ Sean E. Harper
Name: Sean E. Harper